PA
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-0.84%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.48B
AUM Growth
+$119M
(+5%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
6.35%
Top 10 Holdings %
Top 10 Hldgs %
35.06%
Holding
3,425
New
363
Increased
1,606
Reduced
626
Closed
190
Avg Time Held Equity + Options
2.6
years
Top 10 Avg Time Held Equity + Options
2
years
Top 20 Avg Time Held Equity + Options
2.1
years
Avg Time Held Equity only
2.6
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$24.8M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$24.7M |
| 3 |
iShares Core US REIT ETF
USRT
|
+$23.7M |
| 4 |
Coupang
CPNG
|
+$22M |
| 5 |
FTOC
FTAC Olympus Acquisition Corp. Class A Ordinary Shares
FTOC
|
+$15.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Medical Devices ETF
IHI
|
+$15.9M |
| 2 |
iShares Global Tech ETF
IXN
|
+$14.7M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$9.94M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$3.22M |
| 5 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.99% |
| 2 | Technology | 15.91% |
| 3 | Financials | 8.1% |
| 4 | Healthcare | 5.94% |
| 5 | Consumer Discretionary | 5.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Bristol-Myers Squibb
BMY
$121B
| $3.04M | 0.12% |
51,425
+999
| +2% | +$65.8K |
2016 Q4
19 quarters
|
|
127
Block Inc
XYZ
$45.6B
| $3.02M | 0.12% |
12,603
+4,111
| +48% | +$1.06M |
2016 Q4
19 quarters
|
|
128
Vanguard Morningstar Mega Cap ETF
MGC
$10.4B
| $3.02M | 0.12% |
19,800
-488
| -2% | -$76.7K |
2016 Q4
19 quarters
|
|
129
iShares US Technology ETF
IYW
$25.9B
| $3M | 0.12% |
29,592
| – | – |
2016 Q4
19 quarters
|
|
130
Arcus Biosciences
RCUS
$2.87B
| $2.96M | 0.12% |
84,983
-242
| -0.3% | -$7.53K |
2019 Q2
9 quarters
|
|
131
Coca-Cola
KO
$395B
| $2.96M | 0.12% |
56,424
+937
| +2% | +$52.2K |
2016 Q4
19 quarters
|
|
132
CVS Health
CVS
$116B
| $2.93M | 0.12% |
34,522
+4,284
| +14% | +$359K |
2016 Q4
19 quarters
|
|
133
Vanguard Short-Term Corporate Bond ETF
VCSH
$43.9B
| $2.92M | 0.12% |
35,483
-4,557
| -11% | -$377K |
2016 Q4
19 quarters
|
|
134
iShares Russell 1000 Growth ETF
IWF
$127B
| $2.92M | 0.12% |
42,632
-16,868
| -28% | -$1.19M |
2016 Q4
19 quarters
|
|
135
Morgan Stanley
MS
$285B
| $2.88M | 0.12% |
29,651
+1,058
| +4% | +$105K |
2016 Q4
19 quarters
|
|
136
Vanguard Total International Stock ETF
VXUS
$161B
| $2.85M | 0.11% |
45,025
+677
| +2% | +$44.2K |
2017 Q1
18 quarters
|
|
137
Mondelez International
MDLZ
$79.9B
| $2.81M | 0.11% |
48,369
+278
| +0.6% | +$17.3K |
2016 Q4
19 quarters
|
|
138
Snap
SNAP
$10.3B
| $2.8M | 0.11% |
37,905
-12,107
| -24% | -$875K |
2017 Q2
17 quarters
|
|
139
Schwab US Large- Cap ETF
SCHX
$74.4B
| $2.78M | 0.11% |
160,440
-234
| -0.1% | -$4.17K |
2016 Q4
19 quarters
|
|
140
American Tower
AMT
$83.6B
| $2.75M | 0.11% |
10,368
+190
| +2% | +$54.2K |
2016 Q4
19 quarters
|
|
141
Stryker
SYK
$108B
| $2.7M | 0.11% |
10,235
+1,258
| +14% | +$336K |
2016 Q4
19 quarters
|
|
142
United Parcel Service
UPS
$81.5B
| $2.68M | 0.11% |
14,740
+520
| +4% | +$103K |
2016 Q4
19 quarters
|
|
143
Honeywell
HON
$65.8B
| $2.62M | 0.11% |
13,109
-190
| -1% | -$40.5K |
2016 Q4
19 quarters
|
|
144
iShares Russell 2000 Value ETF
IWN
$13.6B
| $2.57M | 0.1% |
16,063
-492
| -3% | -$79K |
2016 Q4
19 quarters
|
|
145
Allstate
ALL
$59.7B
| $2.48M | 0.1% |
19,495
+790
| +4% | +$104K |
2016 Q4
19 quarters
|
|
146
McDonald's
MCD
$169B
| $2.46M | 0.1% |
10,223
+106
| +1% | +$25.3K |
2016 Q4
19 quarters
|
|
147
Invesco S&P 500 Quality ETF
SPHQ
$18.8B
| $2.44M | 0.1% |
50,239
-8,538
| -15% | -$427K |
2018 Q2
13 quarters
|
|
148
Schwab US Large-Cap Value ETF
SCHV
$15.4B
| $2.4M | 0.1% |
106,548
+15,678
| +17% | +$363K |
2016 Q4
19 quarters
|
|
149
Moderna
MRNA
$90.3B
| $2.37M | 0.1% |
6,146
+2,787
| +83% | +$1.03M |
2019 Q1
10 quarters
|
|
150
Vanguard Morningstar Growth ETF
VUG
$232B
| $2.33M | 0.09% |
48,282
-6,372
| -12% | -$317K |
2016 Q4
19 quarters
|
|
Similar funds
AAM
GRP
KGA
WHRC
AWA
SWP
CRC
MIP
Parallel Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Parallel Advisors held 3,425 positions worth $2.48B, up 5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Parallel Advisors deployed $158M of net new capital in Q3 2021, opening 363 new positions and adding to 1,606 existing holdings. Its largest new stake was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 53% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares US Medical Devices ETF, an estimated $15.9M trimmed.
- Parallel Advisors's largest Q3 2021 buy was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
- Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q3 2021, an estimated $24.8M increase.
- Parallel Advisors's biggest Q3 2021 reduction was iShares US Medical Devices ETF, cutting an estimated $15.9M.
- Parallel Advisors fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $1.71M.
- Parallel Advisors's ten largest holdings make up 35% of its $2.48B portfolio in Q3 2021.
- Parallel Advisors opened 363 new positions and closed 190 in Q3 2021.
- Parallel Advisors's portfolio value rose 5% quarter-over-quarter to $2.48B.
Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.